
Sign up to save your podcasts
Or
Join Dr. Anna Wolska and Dr. Jordan Roberts, a pediatric rheumatologist, as they explore the use of Rituximab in treating childhood-onset systemic lupus erythematosus (SLE). They discuss key factors for healthcare providers when prescribing Rituximab to children and adolescents, especially for severe cases like lupus nephritis and CNS involvement. Dr. Roberts presents recent research on Rituximab’s safety, highlighting increased infection risks and the need for targeted prevention strategies. Tune in for expert insights on the latest advancements, challenges, and future directions in pediatric lupus treatment.
Read the paper published in LSM - https://doi.org/10.1136/lupus-2024-001210
3.9
1414 ratings
Join Dr. Anna Wolska and Dr. Jordan Roberts, a pediatric rheumatologist, as they explore the use of Rituximab in treating childhood-onset systemic lupus erythematosus (SLE). They discuss key factors for healthcare providers when prescribing Rituximab to children and adolescents, especially for severe cases like lupus nephritis and CNS involvement. Dr. Roberts presents recent research on Rituximab’s safety, highlighting increased infection risks and the need for targeted prevention strategies. Tune in for expert insights on the latest advancements, challenges, and future directions in pediatric lupus treatment.
Read the paper published in LSM - https://doi.org/10.1136/lupus-2024-001210
38 Listeners
5 Listeners
51 Listeners
8 Listeners
5 Listeners
3 Listeners
2 Listeners
4 Listeners
9 Listeners
38 Listeners
14 Listeners
1 Listeners
51 Listeners
0 Listeners
6 Listeners
11,857 Listeners
500 Listeners
123 Listeners
3 Listeners
112,335 Listeners
3 Listeners
25 Listeners
368,276 Listeners
23 Listeners
47,957 Listeners
68 Listeners
33 Listeners
29,147 Listeners
4 Listeners
45 Listeners
20,143 Listeners
2 Listeners
2 Listeners
0 Listeners